Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease

Peripheral artery disease (PAD) is associated with high cardiovascular mortality and a poor quality of life. The AT1-receptor blocker telmisartan has been shown to have pleiotropic effects and it may also improve endothelial function. The aim of this study was to analyze the effects of telmisartan o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zankl, Alexandra R. (Author) , Ivandic, Boris (Author) , Andrassy, Martin (Author) , Volz, Hans Christian (Author) , Krumsdorf, Ulrike (Author) , Blessing, Erwin (Author) , Katus, Hugo (Author) , Tiefenbacher, Christiane (Author)
Format: Article (Journal)
Language:English
Published: 2010
In: Clinical research in cardiology
Year: 2010, Volume: 99, Issue: 12, Pages: 787-794
ISSN:1861-0692
DOI:10.1007/s00392-010-0184-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-010-0184-0
Get full text
Author Notes:A.R. Zankl, B. Ivandic, M. Andrassy, H.C. Volz, U. Krumsdorf, E. Blessing, H.A. Katus, C.P. Tiefenbacher
Description
Summary:Peripheral artery disease (PAD) is associated with high cardiovascular mortality and a poor quality of life. The AT1-receptor blocker telmisartan has been shown to have pleiotropic effects and it may also improve endothelial function. The aim of this study was to analyze the effects of telmisartan on absolute walking distance (WD) and endothelial function in patients with PAD.
Item Description:Published: 08 July 2010
Gesehen am 17.04.2024
Physical Description:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-010-0184-0